News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
236 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17678)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Peer Reviewed Article Highlights Efficacy and Safety of Jeuveau® in Patients with Skin of Color
Evolus, Inc. announced a peer reviewed journal article was published in Dermatologic Surgery highlighting the efficacy and safety of prabotulinumtoxinA for the treatment of moderate to severe glabellar lines, also known as frown lines between the eyes, in adult patients with Skin of Color.
June 24, 2021
·
9 min read
Business
Quantgene Expands Their Leadership By Hiring David Herrmann as Chief Commercial Officer
Herrmann joins Quantgene from Johnson & Johnson executive ranks, positioning the company for strategic growth in innovative precision medicine.
June 24, 2021
·
2 min read
Business
IgGenix Announces Jessica Grossman, M.D., as Chief Executive Officer
IgGenix, Inc. announced that Jessica Grossman, M.D., has joined IgGenix as chief executive officer (CEO).
June 24, 2021
·
2 min read
Business
Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China
The formal launch of the BGI/Natera Signatera Assay is the next step towards achieving global access to personalized ctDNA testing
June 24, 2021
·
5 min read
Biotech Beach
PharmaCyte Biotech Provides Update on Status of Activities to Lift Clinical Hold
PharmaCyte Biotech, Inc. today announced the efforts being undertaken by the Company to have the U.S. Food and Drug Administration (FDA) clinical hold lifted.
June 24, 2021
·
8 min read
BioMidwest
UM School of Medicine Receives Award for Research on Aging and Cognitive Function
The Dr. M. Lee Pearce Foundation, Inc., established in 1984, has announced a donation to the University of Miami’s School of Medicine in support of its research on aging and cognitive function.
June 24, 2021
·
2 min read
Pharm Country
Oculogica’s New Patent Opens Potential for a CTE Test for Live SubjectsOculogica receives ground-breaking patent to assess CTE via its eye-tracking technology.
Oculogica, a leader in concussion diagnosis and categorization, with the only FDA-cleared technology that aids in the diagnosis of concussion without the need for a pre-injury baseline test, announced the granting of U.S. Patent No. 11,013,441 by the U.S. Patent and Trademark Office.
June 24, 2021
·
4 min read
Axiom Presents “Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites” at Clinical Operations in Oncology Trials 2021
Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting on June 24, 2021, at the Clinical Operations in Oncology Trials Conference.
June 24, 2021
·
2 min read
Pharm Country
Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System to Treat Severe to Profound Sensorineural Hearing Loss
Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s).
June 24, 2021
·
4 min read
Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer
Prof. Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines
June 24, 2021
·
8 min read
Previous
8 of 24
Next